Enovis (ENOV) Other Accumulated Expenses (2010 - 2011)
Enovis' (ENOV) quarterly Other Accumulated Expenses came in at $80.4 million in Q4 2011, up 75.15% year-on-year from $45.9 million in Q4 2010, and up 26.97% on a QoQ basis from $63.4 million in Q3 2011.
Enovis (ENOV) Other Accumulated Expenses (2010 - 2011) Analysis & Trends
Enovis (ENOV) has 2 years of Other Accumulated Expenses data on file, last reported at $80.4 million in Q4 2011.
- On a quarterly basis, Other Accumulated Expenses rose 75.15% year-over-year to $80.4 million in Q4 2011; TTM through Dec 2011 was $80.4 million, a 75.15% increase from a year earlier, with the FY2011 full-year figure at $80.4 million, up 75.15% from the prior year.
- Other Accumulated Expenses for Q4 2011 stood at $80.4 million, up from $63.4 million in the prior quarter.
- Over the last five years, Other Accumulated Expenses for ENOV reached as high as $80.4 million in Q4 2011 and fell as low as $45.9 million in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Enovis | 1.61 Bn | 1.58 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 80.44 Mn |
| Sep 30, 2011 | 63.35 Mn |
| Jul 1, 2011 | 50.03 Mn |
| Dec 31, 2010 | 45.93 Mn |